Oasis Centre for Reproductive Medicine raises $6.2 million investment from India Life Science Fund II

Oasis Centre for Reproductive Medicine, one of the leading and largest chains of in-vitro fertilisation (IVF) centres in South India, announced today that it has raised $6.2 million (INR 40 crore) from India Life Sciences Fund II.

Hyderabad, Telangana, October 10, 2016 /India PRwire/ -- Oasis Centre for Reproductive Medicine, one of the leading and largest chains of in-vitro fertilisation (IVF) centres in South India, announced today that it has raised $6.2 million (INR 40 crore) from India Life Sciences Fund II.

The investment will help the company in establishing more centres in the country and introducing advanced assisted reproductive technology (ART) for infertility treatments. This will also allow the six-year-old company to focus on creating value for all the stakeholders and setting a benchmark for the industry.

Founded in Hyderabad in 2009 by renowned infertility specialist Dr. Durga G Rao and seasoned entrepreneur Kiran Gadela, Oasis today is recognised as the trusted provider of advanced fertility treatments, providing a unique blend of high-level medical expertise and personalised management to couples seeking fertility treatments. The company was recently recognised as the #1 IVF centre in the Andhra Pradesh and Telangana region and positioned as one of India's leading single IVF speciality chains.

The IVF market is predicted to grow at a CAGR of 10.1% in the next five years to reach INR 5027.57 crore (US $ 756 million) by 2021, according to a research report by MarketsandMarkets. With infertility being a huge unmet need, Dr. Anula K Jayasuriya, Managing Director, InvAscent, the investment advisor to EILSF (Evolvence India Life Sciences Fund) and India Life Sciences Fund II, explained, why Oasis was the first choice to invest in this industry.

"We looked for a leadership team that operates at high-quality standards and delivers positive outcomes. Oasis is poised for a good growth with Dr. Durga Rao bringing in the medical expertise and Kiran Gadela's entrepreneurial skills. I am pleased to join the Oasis' board as a director," said Dr. Anula K Jayasuriya.

"Since inception, Oasis' key focus has been to establish a centre of excellence with transparent, ethical and evidence-based practice to treat infertility," said Kiran Gadela, co-founder and Managing Director at Oasis. "India Lifesciences Fund backing us is further testimony to the quality of service we provide at Oasis. The investment would be used for starting 20 more centres in the next 5 years, with the primary focus on expansion in South India," he added.

"Oasis, which has a strong focus on research, will also create extensive training programmes in both clinical and embryology services. We have developed world-class systems, processes and protocols and our multidisciplinary teams work diligently to implement them. This is reflected in our excellent results," said Dr. Durga G. Rao, the co-founder, and Medical Director at Oasis.

NeevCorporate Advisors, a Bengaluru-based advisory that focuses on assisting healthcare, lifesciences and med-tech companies based in India, was the financial advisor for this transaction.

Notes to Editor

About Oasis:

Oasis Centre for Reproductive Medicine is a chain of 'one-stop' day care clinics which provide comprehensive care in advanced fertility treatments. Oasis is an ISO 2001 certified organisation and is a unit of the entity Sadguru Healthcare Services Pvt Ltd., which offers state-of-the-art services in the Indian healthcare industry by leveraging latest technologies along with proven, evidence-based international medical practices.

Oasis is also a member of the European Society of Human Reproduction and Embryology (ESHRE), The American Society for Reproductive Medicine (ASRM), The Federation of Obstetric and Gynaecological Societies of India (FOGSI), and is registered with the Indian Council for Medical Research (ICMR).

About the Founders:



About India Life Sciences Fund II:

India Life Sciences Fund was established in 2006 and provides growth capital to companies operating in the Indian healthcare sectors. The firm has made several deals in the pharma , medical devices and healthcare services space, including cancer care network HealthCare Global Enterprises, Glandpharma (both exited), Chennai-based eye care chain Dr Agarwal's Healthcare among others.

Journalists and Bloggers
Visit India PRwire for Journalists for releases, photos, email alerts and customized feeds just for Media.

If you have any query regarding information in the press releases, please contact the company listed in the press release itself. Please do not call India PRwire, we will be unable to assist you with your inquiry.